Vibe Bioscience Ltd (TSE:VIBE)
:VIBE
Want to see TSE:VIBE full AI Analyst Report?
VIBE Stock Chart & Stats
C$0.06
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.06
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.30 - C$1.50
Previous CloseN/A
Volume81.00K
Average Volume (3M)6.19K
Market Cap
C$323.91K
Enterprise ValueC$1.71M
Total Cash (Recent Filing)C$909.58K
Total Debt (Recent Filing)C$2.38M
Price to Earnings (P/E)―
Beta3.59
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.51
Shares Outstanding1,079,699
10 Day Avg. Volume10,465
30 Day Avg. Volume6,194
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)>-0.01
Price to Sales (P/S)0.00224
P/FCF Ratio2.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthA large TTM revenue rebound indicates the company regained commercial traction and demand for its products. Sustained top-line growth over multiple quarters would support scale, improve unit economics, and provide a base for further margin expansion and reinvestment without relying solely on financing.
Margin Improvement & Profitability TrendMaterial improvement in gross margin and positive EBIT/EBITDA signal that core operations are becoming profitable and that unit economics are improving. If sustained, this creates operating leverage that can convert incremental revenue into durable cash flow and reduce dependence on external capital.
Cash Generation TurnaroundThe shift to positive operating and free cash flow demonstrates the company can convert improved earnings into cash. Persistent positive FCF would reduce refinancing risk, allow targeted reinvestment in R&D or commercialization, and lengthen the firm's funding runway without dilutive raises.
Bears Say
Negative Equity / Capital StructureNegative shareholders’ equity reflects accumulated losses and a depleted capital cushion. This structural weakness restricts financial flexibility, raises the risk of covenant constraints or distress in downturns, and makes future financing more dilutive or costly over the medium term.
Continued Net LossesDespite operational improvements, a persistent net loss implies the company still needs external financing or high cash conversion to reach sustainable profitability. Ongoing losses limit ability to self-fund growth, increase reliance on capital markets, and leave outcomes sensitive to cost pressures or revenue setbacks.
Cash Flow Scale & VolatilityOperating and free cash flow are positive but small and historically volatile. Limited cash generation relative to revenue reduces the company's buffer against shocks, constrains consistent reinvestment, and means a reversal in sales or margin trends could quickly strain liquidity and necessitate external funding.
Vibe Bioscience Ltd News
VIBE FAQ
What was Vibe Bioscience Ltd’s price range in the past 12 months?
Vibe Bioscience Ltd lowest stock price was C$0.30 and its highest was C$1.50 in the past 12 months.
What is Vibe Bioscience Ltd’s market cap?
Vibe Bioscience Ltd’s market cap is C$323.91K.
When is Vibe Bioscience Ltd’s upcoming earnings report date?
Vibe Bioscience Ltd’s upcoming earnings report date is Aug 27, 2026 which is in 88 days.
How were Vibe Bioscience Ltd’s earnings last quarter?
Currently, no data Available
Is Vibe Bioscience Ltd overvalued?
According to Wall Street analysts Vibe Bioscience Ltd’s price is currently Overvalued.
Does Vibe Bioscience Ltd pay dividends?
Vibe Bioscience Ltd does not currently pay dividends.
What is Vibe Bioscience Ltd’s EPS estimate?
Vibe Bioscience Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vibe Bioscience Ltd have?
Vibe Bioscience Ltd has 1,079,699 shares outstanding.
What happened to Vibe Bioscience Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Vibe Bioscience Ltd?
Currently, no hedge funds are holding shares in TSE:VIBE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vibe Bioscience Ltd
Vibe Growth Corporation engages in the cultivation, production, retail, and distribution of cannabis for recreation and medicinal. The company operates five dispensaries, one distribution, and two cultivation operations, as well as sells its products through its e-commerce platform under the Vibe By California brand. It also involved in the indoor cultivation; commercial distribution and transportation; e-commerce and home delivery; and manufacturing of marijuana products. The company was formerly known as Vibe Bioscience Ltd. and changed its name to Vibe Growth Corporation in October 2020. Vibe Growth Corporation was incorporated in 2020 and is headquartered in Sacramento, California.
Technical Analysis
Molecule Holdings
―
Global Hemp
―
―
Asia Green Biotechnology Corp.
―
Xebra Brands Ltd.
―
Options Prices
Currently, No data available
---